Business Description
CellSource Co Ltd
ISIN : JP3423580004
Total Employee Number:
179Description
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 189.48 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-EBITDA | 0.07 | |||||
Interest Coverage | 222.59 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 5.91 | |||||
Beneish M-Score | -2.71 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.6 | |||||
3-Year EBITDA Growth Rate | -43.1 | |||||
3-Year EPS without NRI Growth Rate | -72.8 | |||||
3-Year FCF Growth Rate | -28.4 | |||||
3-Year Book Growth Rate | 14.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 152.21 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.59 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.12 | |||||
9-Day RSI | 49.55 | |||||
14-Day RSI | 48.47 | |||||
3-1 Month Momentum % | -20.55 | |||||
6-1 Month Momentum % | -24.7 | |||||
12-1 Month Momentum % | -54.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.97 | |||||
Quick Ratio | 10.35 | |||||
Cash Ratio | 9.57 | |||||
Days Inventory | 66.9 | |||||
Days Sales Outstanding | 31.52 | |||||
Days Payable | 19.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.53 | |||||
Dividend Payout Ratio | 1.03 | |||||
Forward Dividend Yield % | 1.53 | |||||
5-Year Yield-on-Cost % | 1.52 | |||||
3-Year Average Share Buyback Ratio | -2 | |||||
Shareholder Yield % | 2.07 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 57.57 | |||||
Operating Margin % | 7.51 | |||||
Net Margin % | 1.93 | |||||
EBITDA Margin % | 10.47 | |||||
FCF Margin % | 8.78 | |||||
OCF Margin % | 12.17 | |||||
ROE % | 1.18 | |||||
ROA % | 1.01 | |||||
ROIC % | 4.51 | |||||
3-Year ROIIC % | -70.92 | |||||
ROC (Joel Greenblatt) % | 14.69 | |||||
ROCE % | 3.01 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 89.6 | |||||
Forward PE Ratio | 59.27 | |||||
PE Ratio without NRI | 65.98 | |||||
PS Ratio | 1.72 | |||||
PB Ratio | 1.06 | |||||
Price-to-Tangible-Book | 1.08 | |||||
Price-to-Free-Cash-Flow | 19.69 | |||||
Price-to-Operating-Cash-Flow | 14.21 | |||||
EV-to-EBIT | 7.99 | |||||
EV-to-EBITDA | 4.09 | |||||
EV-to-Revenue | 0.42 | |||||
EV-to-FCF | 5.25 | |||||
Price-to-GF-Value | 0.41 | |||||
Price-to-Projected-FCF | 0.67 | |||||
Price-to-Graham-Number | 1.78 | |||||
| Price-to-Net-Current-Asset-Value | 1.41 | |||||
| Price-to-Net-Cash | 1.67 | |||||
Earnings Yield (Greenblatt) % | 12.52 | |||||
FCF Yield % | 5.09 | |||||
Forward Rate of Return (Yacktman) % | -5.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CellSource Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 3,666.54 | ||
| EPS (TTM) (円) | 3.56 | ||
| Beta | 0.1775 | ||
| 3-Year Sharpe Ratio | -1.75 | ||
| 3-Year Sortino Ratio | -1.7 | ||
| Volatility % | 27.61 | ||
| 14-Day RSI | 48.47 | ||
| 14-Day ATR (円) | 12.38694 | ||
| 20-Day SMA (円) | 312.25 | ||
| 12-1 Month Momentum % | -54.06 | ||
| 52-Week Range (円) | 294 - 736 | ||
| Shares Outstanding (Mil) | 19.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CellSource Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CellSource Co Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| JPY 5.000000 Cash Dividend | 2025-10-30 | 503.00 (-2.52%) | ||
| JPY 5.000000 Cash Dividend | 2024-10-30 | 1,188.00 (+1.19%) | ||
| 3:1 Stock Split | 2021-10-28 | 6,726.67 (-0.25%) | ||
| 3:1 Stock Split | 2020-10-29 | 3,158.89 (+0.00%) |
Show
Entries
CellSource Co Ltd Frequently Asked Questions
What is CellSource Co Ltd(TSE:4880)'s stock price today?
The current price of TSE:4880 is 円319.00. The 52 week high of TSE:4880 is 円736.00 and 52 week low is 円294.00.
When is next earnings date of CellSource Co Ltd(TSE:4880)?
The next earnings date of CellSource Co Ltd(TSE:4880) is .
Does CellSource Co Ltd(TSE:4880) pay dividends? If so, how much?
The Dividend Yield %  of CellSource Co Ltd(TSE:4880) is 1.53% (As of Today), Highest Dividend Payout Ratio of CellSource Co Ltd(TSE:4880) was 4.63. The lowest was 0.11. And the median was 0.52. The  Forward Dividend Yield % of CellSource Co Ltd(TSE:4880) is 1.53%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on CellSource Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers